The global market for Chronic Idiopathic Constipation (CIC) Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Chronic idiopathic constipation (CIC) is a health condition in which a person experiences chronic symptoms of constipation, yet no visible cause can be identified through standard diagnostic testing. The term idiopathic is used because it means there is no known cause. CIC includes symptoms of difficult, infrequent, or incomplete bowel movements.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Chronic Idiopathic Constipation (CIC) Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chronic Idiopathic Constipation (CIC) Drugs.

The Chronic Idiopathic Constipation (CIC) Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Chronic Idiopathic Constipation (CIC) Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Chronic Idiopathic Constipation (CIC) Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Chronic Idiopathic Constipation (CIC) Drugs Market Report

Report Metric	Details
Report Name	Chronic Idiopathic Constipation (CIC) Drugs Market
CAGR	5%
Segment by Type	Lubiprostone Linaclotide Others
Segment by Application	Hospitals & Clinics Ambulatory Surgical Centres Long Term Care Centres Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Actavis, Chugai Pharmaceutical, Ferring International Center, Synergy Pharmaceuticals, Pfizer, GlaxoSmithKline, Roche Holding, Sanofi, Bayer, Salix Pharmaceuticals, Sucampo Pharmaceuticals, Ironwood Pharmaceuticals, Progenics Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Chronic Idiopathic Constipation (CIC) Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Chronic Idiopathic Constipation (CIC) Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Chronic Idiopathic Constipation (CIC) Drugs Market report?

Ans: The main players in the Chronic Idiopathic Constipation (CIC) Drugs Market are Actavis, Chugai Pharmaceutical, Ferring International Center, Synergy Pharmaceuticals, Pfizer, GlaxoSmithKline, Roche Holding, Sanofi, Bayer, Salix Pharmaceuticals, Sucampo Pharmaceuticals, Ironwood Pharmaceuticals, Progenics Pharmaceuticals

What are the Application segmentation covered in the Chronic Idiopathic Constipation (CIC) Drugs Market report?

Ans: The Applications covered in the Chronic Idiopathic Constipation (CIC) Drugs Market report are Hospitals & Clinics, Ambulatory Surgical Centres, Long Term Care Centres, Others

What are the Type segmentation covered in the Chronic Idiopathic Constipation (CIC) Drugs Market report?

Ans: The Types covered in the Chronic Idiopathic Constipation (CIC) Drugs Market report are Lubiprostone, Linaclotide, Others

1 Chronic Idiopathic Constipation (CIC) Drugs Market Overview

1.1 Product Definition

1.2 Chronic Idiopathic Constipation (CIC) Drugs by Type

1.2.1 Global Chronic Idiopathic Constipation (CIC) Drugs Market Value Comparison by Type (2024 VS 2031)

1.2.2 Lubiprostone

1.2.3 Linaclotide

1.2.4 Others

1.3 Chronic Idiopathic Constipation (CIC) Drugs by Application

1.3.1 Global Chronic Idiopathic Constipation (CIC) Drugs Market Value by Application (2024 VS 2031)

1.3.2 Hospitals & Clinics

1.3.3 Ambulatory Surgical Centres

1.3.4 Long Term Care Centres

1.3.5 Others

1.4 Global Chronic Idiopathic Constipation (CIC) Drugs Market Size Estimates and Forecasts

1.4.1 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue 2020-2031

1.4.2 Global Chronic Idiopathic Constipation (CIC) Drugs Sales 2020-2031

1.4.3 Global Chronic Idiopathic Constipation (CIC) Drugs Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Chronic Idiopathic Constipation (CIC) Drugs Market Competition by Manufacturers

2.1 Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Manufacturers (2020-2025)

2.2 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Chronic Idiopathic Constipation (CIC) Drugs Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Chronic Idiopathic Constipation (CIC) Drugs, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Chronic Idiopathic Constipation (CIC) Drugs, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Chronic Idiopathic Constipation (CIC) Drugs, Product Type & Application

2.7 Global Key Manufacturers of Chronic Idiopathic Constipation (CIC) Drugs, Date of Enter into This Industry

2.8 Global Chronic Idiopathic Constipation (CIC) Drugs Market Competitive Situation and Trends

2.8.1 Global Chronic Idiopathic Constipation (CIC) Drugs Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Chronic Idiopathic Constipation (CIC) Drugs Players Market Share by Revenue

2.8.3 Global Chronic Idiopathic Constipation (CIC) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Chronic Idiopathic Constipation (CIC) Drugs Market Scenario by Region

3.1 Global Chronic Idiopathic Constipation (CIC) Drugs Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Region: 2020-2031

3.2.1 Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Region: 2020-2025

3.2.2 Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Region: 2026-2031

3.3 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Region: 2020-2031

3.3.1 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Region: 2020-2025

3.3.2 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Region: 2026-2031

3.4 North America Chronic Idiopathic Constipation (CIC) Drugs Market Facts & Figures by Country

3.4.1 North America Chronic Idiopathic Constipation (CIC) Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Chronic Idiopathic Constipation (CIC) Drugs Sales by Country (2020-2031)

3.4.3 North America Chronic Idiopathic Constipation (CIC) Drugs Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Chronic Idiopathic Constipation (CIC) Drugs Market Facts & Figures by Country

3.5.1 Europe Chronic Idiopathic Constipation (CIC) Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Chronic Idiopathic Constipation (CIC) Drugs Sales by Country (2020-2031)

3.5.3 Europe Chronic Idiopathic Constipation (CIC) Drugs Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Market Facts & Figures by Region

3.6.1 Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Sales by Region (2020-2031)

3.6.3 Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Chronic Idiopathic Constipation (CIC) Drugs Market Facts & Figures by Country

3.7.1 Latin America Chronic Idiopathic Constipation (CIC) Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Chronic Idiopathic Constipation (CIC) Drugs Sales by Country (2020-2031)

3.7.3 Latin America Chronic Idiopathic Constipation (CIC) Drugs Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Market Facts & Figures by Country

3.8.1 Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Sales by Country (2020-2031)

3.8.3 Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Type (2020-2031)

4.1.1 Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Type (2020-2025)

4.1.2 Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Type (2026-2031)

4.1.3 Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Type (2020-2031)

4.2 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Type (2020-2031)

4.2.1 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Type (2020-2025)

4.2.2 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Type (2026-2031)

4.2.3 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Type (2020-2031)

4.3 Global Chronic Idiopathic Constipation (CIC) Drugs Price by Type (2020-2031)

5 Segment by Application

5.1 Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Application (2020-2031)

5.1.1 Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Application (2020-2025)

5.1.2 Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Application (2026-2031)

5.1.3 Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Application (2020-2031)

5.2 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Application (2020-2031)

5.2.1 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Application (2020-2025)

5.2.2 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Application (2026-2031)

5.2.3 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Application (2020-2031)

5.3 Global Chronic Idiopathic Constipation (CIC) Drugs Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Actavis

6.1.1 Actavis Company Information

6.1.2 Actavis Description and Business Overview

6.1.3 Actavis Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Actavis Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio

6.1.5 Actavis Recent Developments/Updates

6.2 Chugai Pharmaceutical

6.2.1 Chugai Pharmaceutical Company Information

6.2.2 Chugai Pharmaceutical Description and Business Overview

6.2.3 Chugai Pharmaceutical Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Chugai Pharmaceutical Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio

6.2.5 Chugai Pharmaceutical Recent Developments/Updates

6.3 Ferring International Center

6.3.1 Ferring International Center Company Information

6.3.2 Ferring International Center Description and Business Overview

6.3.3 Ferring International Center Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Ferring International Center Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio

6.3.5 Ferring International Center Recent Developments/Updates

6.4 Synergy Pharmaceuticals

6.4.1 Synergy Pharmaceuticals Company Information

6.4.2 Synergy Pharmaceuticals Description and Business Overview

6.4.3 Synergy Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Synergy Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio

6.4.5 Synergy Pharmaceuticals Recent Developments/Updates

6.5 Pfizer

6.5.1 Pfizer Company Information

6.5.2 Pfizer Description and Business Overview

6.5.3 Pfizer Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Pfizer Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio

6.5.5 Pfizer Recent Developments/Updates

6.6 GlaxoSmithKline

6.6.1 GlaxoSmithKline Company Information

6.6.2 GlaxoSmithKline Description and Business Overview

6.6.3 GlaxoSmithKline Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue and Gross Margin (2020-2025)

6.6.4 GlaxoSmithKline Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio

6.6.5 GlaxoSmithKline Recent Developments/Updates

6.7 Roche Holding

6.7.1 Roche Holding Company Information

6.7.2 Roche Holding Description and Business Overview

6.7.3 Roche Holding Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Roche Holding Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio

6.7.5 Roche Holding Recent Developments/Updates

6.8 Sanofi

6.8.1 Sanofi Company Information

6.8.2 Sanofi Description and Business Overview

6.8.3 Sanofi Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Sanofi Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio

6.8.5 Sanofi Recent Developments/Updates

6.9 Bayer

6.9.1 Bayer Company Information

6.9.2 Bayer Description and Business Overview

6.9.3 Bayer Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Bayer Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio

6.9.5 Bayer Recent Developments/Updates

6.10 Salix Pharmaceuticals

6.10.1 Salix Pharmaceuticals Company Information

6.10.2 Salix Pharmaceuticals Description and Business Overview

6.10.3 Salix Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Salix Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio

6.10.5 Salix Pharmaceuticals Recent Developments/Updates

6.11 Sucampo Pharmaceuticals

6.11.1 Sucampo Pharmaceuticals Company Information

6.11.2 Sucampo Pharmaceuticals Description and Business Overview

6.11.3 Sucampo Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Sucampo Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio

6.11.5 Sucampo Pharmaceuticals Recent Developments/Updates

6.12 Ironwood Pharmaceuticals

6.12.1 Ironwood Pharmaceuticals Company Information

6.12.2 Ironwood Pharmaceuticals Description and Business Overview

6.12.3 Ironwood Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue and Gross Margin (2020-2025)

6.12.4 Ironwood Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio

6.12.5 Ironwood Pharmaceuticals Recent Developments/Updates

6.13 Progenics Pharmaceuticals

6.13.1 Progenics Pharmaceuticals Company Information

6.13.2 Progenics Pharmaceuticals Description and Business Overview

6.13.3 Progenics Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue and Gross Margin (2020-2025)

6.13.4 Progenics Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio

6.13.5 Progenics Pharmaceuticals Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Chronic Idiopathic Constipation (CIC) Drugs Industry Chain Analysis

7.2 Chronic Idiopathic Constipation (CIC) Drugs Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Chronic Idiopathic Constipation (CIC) Drugs Production Mode & Process Analysis

7.4 Chronic Idiopathic Constipation (CIC) Drugs Sales and Marketing

7.4.1 Chronic Idiopathic Constipation (CIC) Drugs Sales Channels

7.4.2 Chronic Idiopathic Constipation (CIC) Drugs Distributors

7.5 Chronic Idiopathic Constipation (CIC) Drugs Customer Analysis

8 Chronic Idiopathic Constipation (CIC) Drugs Market Dynamics

8.1 Chronic Idiopathic Constipation (CIC) Drugs Industry Trends

8.2 Chronic Idiopathic Constipation (CIC) Drugs Market Drivers

8.3 Chronic Idiopathic Constipation (CIC) Drugs Market Challenges

8.4 Chronic Idiopathic Constipation (CIC) Drugs Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Actavis

Chugai Pharmaceutical

Ferring International Center

Synergy Pharmaceuticals

Salix Pharmaceuticals

Sucampo Pharmaceuticals

Ironwood Pharmaceuticals

Progenics Pharmaceuticals

List of Tables

Table 1. Global Chronic Idiopathic Constipation (CIC) Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Chronic Idiopathic Constipation (CIC) Drugs Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Chronic Idiopathic Constipation (CIC) Drugs Market Competitive Situation by Manufacturers in 2024

Table 4. Global Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Chronic Idiopathic Constipation (CIC) Drugs Average Price (USD/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Chronic Idiopathic Constipation (CIC) Drugs, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Chronic Idiopathic Constipation (CIC) Drugs, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Chronic Idiopathic Constipation (CIC) Drugs, Product Type & Application

Table 12. Global Key Manufacturers of Chronic Idiopathic Constipation (CIC) Drugs, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Chronic Idiopathic Constipation (CIC) Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Idiopathic Constipation (CIC) Drugs as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Chronic Idiopathic Constipation (CIC) Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Region (2020-2025) & (K Units)

Table 18. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Region (2020-2025)

Table 19. Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Region (2026-2031) & (K Units)

Table 20. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Region (2026-2031)

Table 21. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Region (2020-2025)

Table 23. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Region (2026-2031)

Table 25. North America Chronic Idiopathic Constipation (CIC) Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Chronic Idiopathic Constipation (CIC) Drugs Sales by Country (2020-2025) & (K Units)

Table 27. North America Chronic Idiopathic Constipation (CIC) Drugs Sales by Country (2026-2031) & (K Units)

Table 28. North America Chronic Idiopathic Constipation (CIC) Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Chronic Idiopathic Constipation (CIC) Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Chronic Idiopathic Constipation (CIC) Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Chronic Idiopathic Constipation (CIC) Drugs Sales by Country (2020-2025) & (K Units)

Table 32. Europe Chronic Idiopathic Constipation (CIC) Drugs Sales by Country (2026-2031) & (K Units)

Table 33. Europe Chronic Idiopathic Constipation (CIC) Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Chronic Idiopathic Constipation (CIC) Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Chronic Idiopathic Constipation (CIC) Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Chronic Idiopathic Constipation (CIC) Drugs Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Chronic Idiopathic Constipation (CIC) Drugs Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Chronic Idiopathic Constipation (CIC) Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Chronic Idiopathic Constipation (CIC) Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units) by Type (2020-2025)

Table 51. Global Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units) by Type (2026-2031)

Table 52. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Type (2020-2025)

Table 53. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Type (2026-2031)

Table 54. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Type (2020-2025)

Table 57. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Type (2026-2031)

Table 58. Global Chronic Idiopathic Constipation (CIC) Drugs Price (USD/Unit) by Type (2020-2025)

Table 59. Global Chronic Idiopathic Constipation (CIC) Drugs Price (USD/Unit) by Type (2026-2031)

Table 60. Global Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units) by Application (2020-2025)

Table 61. Global Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units) by Application (2026-2031)

Table 62. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Application (2020-2025)

Table 63. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Application (2026-2031)

Table 64. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Application (2020-2025)

Table 67. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Application (2026-2031)

Table 68. Global Chronic Idiopathic Constipation (CIC) Drugs Price (USD/Unit) by Application (2020-2025)

Table 69. Global Chronic Idiopathic Constipation (CIC) Drugs Price (USD/Unit) by Application (2026-2031)

Table 70. Actavis Company Information

Table 71. Actavis Description and Business Overview

Table 72. Actavis Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 73. Actavis Chronic Idiopathic Constipation (CIC) Drugs Product

Table 74. Actavis Recent Developments/Updates

Table 75. Chugai Pharmaceutical Company Information

Table 76. Chugai Pharmaceutical Description and Business Overview

Table 77. Chugai Pharmaceutical Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 78. Chugai Pharmaceutical Chronic Idiopathic Constipation (CIC) Drugs Product

Table 79. Chugai Pharmaceutical Recent Developments/Updates

Table 80. Ferring International Center Company Information

Table 81. Ferring International Center Description and Business Overview

Table 82. Ferring International Center Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 83. Ferring International Center Chronic Idiopathic Constipation (CIC) Drugs Product

Table 84. Ferring International Center Recent Developments/Updates

Table 85. Synergy Pharmaceuticals Company Information

Table 86. Synergy Pharmaceuticals Description and Business Overview

Table 87. Synergy Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 88. Synergy Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Product

Table 89. Synergy Pharmaceuticals Recent Developments/Updates

Table 90. Pfizer Company Information

Table 91. Pfizer Description and Business Overview

Table 92. Pfizer Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 93. Pfizer Chronic Idiopathic Constipation (CIC) Drugs Product

Table 94. Pfizer Recent Developments/Updates

Table 95. GlaxoSmithKline Company Information

Table 96. GlaxoSmithKline Description and Business Overview

Table 97. GlaxoSmithKline Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 98. GlaxoSmithKline Chronic Idiopathic Constipation (CIC) Drugs Product

Table 99. GlaxoSmithKline Recent Developments/Updates

Table 100. Roche Holding Company Information

Table 101. Roche Holding Description and Business Overview

Table 102. Roche Holding Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 103. Roche Holding Chronic Idiopathic Constipation (CIC) Drugs Product

Table 104. Roche Holding Recent Developments/Updates

Table 105. Sanofi Company Information

Table 106. Sanofi Description and Business Overview

Table 107. Sanofi Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 108. Sanofi Chronic Idiopathic Constipation (CIC) Drugs Product

Table 109. Sanofi Recent Developments/Updates

Table 110. Bayer Company Information

Table 111. Bayer Description and Business Overview

Table 112. Bayer Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 113. Bayer Chronic Idiopathic Constipation (CIC) Drugs Product

Table 114. Bayer Recent Developments/Updates

Table 115. Salix Pharmaceuticals Company Information

Table 116. Salix Pharmaceuticals Description and Business Overview

Table 117. Salix Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 118. Salix Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Product

Table 119. Salix Pharmaceuticals Recent Developments/Updates

Table 120. Sucampo Pharmaceuticals Company Information

Table 121. Sucampo Pharmaceuticals Description and Business Overview

Table 122. Sucampo Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 123. Sucampo Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Product

Table 124. Sucampo Pharmaceuticals Recent Developments/Updates

Table 125. Ironwood Pharmaceuticals Company Information

Table 126. Ironwood Pharmaceuticals Description and Business Overview

Table 127. Ironwood Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 128. Ironwood Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Product

Table 129. Ironwood Pharmaceuticals Recent Developments/Updates

Table 130. Progenics Pharmaceuticals Company Information

Table 131. Progenics Pharmaceuticals Description and Business Overview

Table 132. Progenics Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 133. Progenics Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Product

Table 134. Progenics Pharmaceuticals Recent Developments/Updates

Table 135. Key Raw Materials Lists

Table 136. Raw Materials Key Suppliers Lists

Table 137. Chronic Idiopathic Constipation (CIC) Drugs Distributors List

Table 138. Chronic Idiopathic Constipation (CIC) Drugs Customers List

Table 139. Chronic Idiopathic Constipation (CIC) Drugs Market Trends

Table 140. Chronic Idiopathic Constipation (CIC) Drugs Market Drivers

Table 141. Chronic Idiopathic Constipation (CIC) Drugs Market Challenges

Table 142. Chronic Idiopathic Constipation (CIC) Drugs Market Restraints

Table 143. Research Programs/Design for This Report

Table 144. Key Data Information from Secondary Sources

Table 145. Key Data Information from Primary Sources

Table 146. Authors List of This Report

List of Figures

Figure 1. Product Picture of Chronic Idiopathic Constipation (CIC) Drugs

Figure 2. Global Chronic Idiopathic Constipation (CIC) Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Chronic Idiopathic Constipation (CIC) Drugs Market Share by Type: 2024 & 2031

Figure 4. Lubiprostone Product Picture

Figure 5. Linaclotide Product Picture

Figure 6. Others Product Picture

Figure 7. Global Chronic Idiopathic Constipation (CIC) Drugs Market Value by Application (2020-2031) & (US$ Million)

Figure 8. Global Chronic Idiopathic Constipation (CIC) Drugs Market Share by Application: 2024 & 2031

Figure 9. Hospitals & Clinics

Figure 10. Ambulatory Surgical Centres

Figure 11. Long Term Care Centres

Figure 12. Others

Figure 13. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Chronic Idiopathic Constipation (CIC) Drugs Market Size (2020-2031) & (US$ Million)

Figure 15. Global Chronic Idiopathic Constipation (CIC) Drugs Sales (2020-2031) & (K Units)

Figure 16. Global Chronic Idiopathic Constipation (CIC) Drugs Average Price (USD/Unit) & (2020-2031)

Figure 17. Chronic Idiopathic Constipation (CIC) Drugs Report Years Considered

Figure 18. Chronic Idiopathic Constipation (CIC) Drugs Sales Share by Manufacturers in 2024

Figure 19. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Share by Manufacturers in 2024

Figure 20. Global 5 and 10 Largest Chronic Idiopathic Constipation (CIC) Drugs Players: Market Share by Revenue in Chronic Idiopathic Constipation (CIC) Drugs in 2024

Figure 21. Chronic Idiopathic Constipation (CIC) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 22. Global Chronic Idiopathic Constipation (CIC) Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 23. North America Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Country (2020-2031)

Figure 24. North America Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Country (2020-2031)

Figure 25. U.S. Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Canada Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. Europe Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Country (2020-2031)

Figure 28. Europe Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Country (2020-2031)

Figure 29. Germany Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. France Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. U.K. Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Italy Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Russia Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Region (2020-2031)

Figure 35. Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Region (2020-2031)

Figure 36. China Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. Japan Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. South Korea Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. India Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Australia Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Taiwan Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Indonesia Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Thailand Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Malaysia Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Philippines Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Latin America Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Country (2020-2031)

Figure 47. Latin America Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Country (2020-2031)

Figure 48. Mexico Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Brazil Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Argentina Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Country (2020-2031)

Figure 52. Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Country (2020-2031)

Figure 53. Turkey Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. Saudi Arabia Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. U.A.E Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 56. Global Sales Market Share of Chronic Idiopathic Constipation (CIC) Drugs by Type (2020-2031)

Figure 57. Global Revenue Market Share of Chronic Idiopathic Constipation (CIC) Drugs by Type (2020-2031)

Figure 58. Global Chronic Idiopathic Constipation (CIC) Drugs Price (USD/Unit) by Type (2020-2031)

Figure 59. Global Sales Market Share of Chronic Idiopathic Constipation (CIC) Drugs by Application (2020-2031)

Figure 60. Global Revenue Market Share of Chronic Idiopathic Constipation (CIC) Drugs by Application (2020-2031)

Figure 61. Global Chronic Idiopathic Constipation (CIC) Drugs Price (USD/Unit) by Application (2020-2031)

Figure 62. Chronic Idiopathic Constipation (CIC) Drugs Value Chain

Figure 63. Channels of Distribution (Direct Vs Distribution)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Coronary Imaging Catheter Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-32P14840

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Digital Platform for Chronic Kidney Disease (CKD) Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-20V18395

Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global Continuous Glucose Monitoring Sensor Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-32G20014

Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global Radioactive Iodine Ablation Therapy Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-9U20281

Tue Dec 02 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions